Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-18Clinical Trial Update: Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus. [Phase 4]
Phase 4 trial update evaluating whether pioglitazone plus metformin affects cardiovascular risk in insulin-treated type 2 diabetes mellitus …
-
CLINICAL_TRIALS trial_result · 2010-08-17Clinical Trial Update: Endothelial Effects of Basal Insulin: Detemir Versus Glargine [Phase 4]
A Phase 4 trial comparing the endothelial effects of basal insulins detemir and glargine in adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-17Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs [Phase 4]
A Phase 4 trial assessing the efficacy and safety of Biphasic Insulin Aspart 30 in type 2 diabetes patients not adequately controlled on ora…
-
CLINICAL_TRIALS trial_result · 2010-08-17Clinical Trial Update: Cognitive Behavioral Intervention in Diabetes Self-Management [NA]
This document reports the completion of a clinical trial evaluating a cognitive behavioral intervention to support self-management in adults…
-
CLINICAL_TRIALS trial_result · 2010-08-17Clinical Trial Update: Evaluation of Diabetes Care at Austrian GPs
AstraZeneca-sponsored trial evaluating diabetes care in Austrian general practitioners was terminated before completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2010-08-17Clinical Trial Update: Genetic Variation in OCT1 and Response to Metformin [Phase 4]
A Phase 4 clinical trial examining the influence of OCT1 genetic variation on metformin response in Type 2 Diabetes was withdrawn.
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea [Phase 4]
Phase 4 trial evaluating lacidipine in adults with type 2 diabetes and mild-to-moderate essential hypertension in Korea has completed.
-
FDA approval · 2010-08-13FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) filed by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes [Phase 4]
A Phase 4 trial comparing two insulin therapies in type 2 diabetes to evaluate their effectiveness in lowering blood sugar and safety; resul…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 long-term extension study evaluating the safety of dutogliptin/PHX1149T in Type 2 Diabetes Mellitus has been terminated.
-
CLINICAL_TRIALS research · 2010-08-11Clinical Trial Update: Internet Intervention to Improve Rural Diabetes Care [NA]
A clinical trial evaluating an Internet intervention to improve diabetes care in rural settings has completed enrollment and status is compl…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin [Phase 3]
This Phase 3 study evaluated dutogliptin/PHX1149T for safety and efficacy in adults with type 2 diabetes mellitus on metformin, but the tria…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus [Phase 3]
A long-term Phase 3 study evaluating the safety of dutogliptin/PHX1149T in subjects with type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin [Phase 3]
Phase 3 trial of dutogliptin added to metformin in type 2 diabetes patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Effect of Alcohol on Cephalic Phase Reflex and Gene Expression [NA]
This document reports the completion of a clinical trial (NCT00652405) evaluating the effects of alcohol on cephalic phase reflex and gene e…
-
CLINICAL_TRIALS research · 2010-08-10Clinical Trial Update: The Effects of Breakfast Size on Hormonal Profile in Adults With Type 2 Diabetes Mellitus [NA]
A clinical trial investigates how breakfast size affects hormonal profiles in adults with type 2 diabetes; the trial status is currently unk…
-
FDA approval · 2010-08-06FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2010-08-06Clinical Trial Update: Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin [Phase 3]
A Phase 3 clinical trial assessing self-monitoring of blood glucose and intensive education in adults with Type 2 diabetes not on insulin ha…
-
CLINICAL_TRIALS trial_result · 2010-08-04Clinical Trial Update: The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial comparing liraglutide vs sitagliptin, both combined with metformin, assessing glycemic control in adults with type 2 …
-
CLINICAL_TRIALS trial_result · 2010-08-03Clinical Trial Update: A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179) [Phase 1]
A Phase 1 Merck study evaluating a method to measure glucose-dependent insulin secretion in healthy male volunteers using MK-0431-179; the t…
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: The Impact of Vitamins and Minerals Supplementation on Neuropathy and Nephropathy Complications [Phase 2]
Phase 2 trial evaluating the effect of vitamin and mineral supplementation on neuropathy and nephropathy in type 2 diabetes was completed.
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Comparison of Nutritional Products for People With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating nutritional products for adults with Type 2 diabetes has completed. Sponsor: Abbott Nutrition.
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes [Phase 2, Phase 3]
Completed Phase 2/3 clinical trial evaluating a herbal extract for metabolic parameters in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2) [Phase 4]
Phase 4 clinical trial comparing safety and efficacy of basal insulin Lantus (insulin glargine) versus NPH insulin, added to oral antidiabet…
-
FDA label_change · 2010-07-29FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for ACTOS (pioglitazone) from Takeda Pharmaceuticals America, updating the product labeling.